DBD
DBD
NYSE · Technology

Diebold Nixdorf Inc

$83.81
+2.92 (+3.61%)
Financial Highlights (FY 2026)
Revenue
3.63B
Net Income
90.31M
Gross Margin
26.4%
Profit Margin
2.5%
Rev Growth
+3.2%
D/E Ratio
0.86
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 26.4% 26.4% 62.0% 62.0%
Operating Margin 6.4% 5.7% 23.8% 24.5%
Profit Margin 2.5% 2.4% 21.9% 24.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 3.63B 3.52B 350.37M 397.27M
Gross Profit 958.08M 928.19M 217.38M 246.48M
Operating Income 231.07M 201.48M 83.22M 97.46M
Net Income 90.31M 78.75M 76.72M 98.58M
Gross Margin 26.4% 26.4% 62.0% 62.0%
Operating Margin 6.4% 5.7% 23.8% 24.5%
Profit Margin 2.5% 2.4% 21.9% 24.8%
Rev Growth +3.2% +3.2% +6.5% +14.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 670.44M 670.44M 538.36M 459.72M
Total Equity 780.67M 780.67M 1.05B 1.01B
D/E Ratio 0.86 0.86 0.51 0.46
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 352.75M 324.66M 102.75M 125.92M
Free Cash Flow 87.64M 93.06M